The Cancer Genetics and Genomics Laboratory (CGL) at BC Cancer will begin offering DPYD testing for the entire province effective March 1, 2023. DPYD screening is recommended for patients whose treatment plans include 5-fluorouracil (5FU) or capecitabine. Additional details regarding this new test can be found in the memo